Semax Selank Spray

Research Benefits

• Dual Cognitive Enhancement: Combines Semax's BDNF-mediated neurotropic effects with Selank's GABAergic anxiolytic activity for comprehensive cognitive research
• Neuroprotection: Both peptides independently demonstrate neuroprotective properties through distinct mechanisms, offering broad-spectrum neural support
• Memory & Learning: Semax's enhancement of attention and memory processing paired with Selank's reduction of anxiety-induced cognitive interference
• Mood Regulation Research: Selank's modulation of enkephalin metabolism combined with Semax's dopaminergic and serotonergic effects
• Immune Modulation: Both peptides have documented immunomodulatory properties, with Selank specifically studied for cytokine balance

Mechanism of Action

Semax Pathway (ACTH 4-10 analog)

• Upregulates BDNF and NGF expression in hippocampal and cortical neurons
• Modulates dopaminergic and serotonergic neurotransmission
• Enhances TrkB receptor signaling for synaptic plasticity
• Stimulates adenylate cyclase activity in neural tissue

Selank Pathway (Tuftsin analog)

• Allosteric modulation of GABA-A receptor complex, enhancing inhibitory neurotransmission
• Inhibits enkephalinase, increasing endogenous enkephalin levels
• Modulates IL-6 and other cytokine expression for neuroimmune regulation
• Influences monoamine oxidase activity, affecting serotonin and norepinephrine levels

The combination provides complementary cognitive support: Semax drives neurotropic growth and attention, while Selank reduces anxiety and stabilizes emotional tone, creating conditions for optimal cognitive performance research.

Research Protocol

For research purposes only. Not for human consumption.

• Typical Research Dose: 200-600 mcg Semax + 200-500 mcg Selank per administration
• Administration: Intranasal spray is the most common route in published research
• Research Cycle: 14-30 day cycles reported in Russian clinical literature
• Frequency: 2-3 times daily in most published protocols

Notes

• Both peptides are approved medications in Russia with established research protocols
• Morning and afternoon administration aligns with cognitive demand periods in published study designs

Safety & Storage

• Storage: Refrigerate at 2-8 °C; protect from light
• Stability: Nasal spray formulations typically stable for 30 days when refrigerated

Research Considerations

• Both Semax and Selank have extensive safety profiles from Russian regulatory approval and years of clinical use as medications
• Selank's GABAergic activity may potentiate sedative compounds; consider protocol design
• Semax may influence blood pressure through ACTH-related pathways at higher doses
• For research use only in the United States

Frequently Asked Questions

• Why combine Semax and Selank?

  Semax and Selank address complementary aspects of cognitive function. Semax enhances neurotropic growth, attention, and memory through BDNF upregulation, while Selank reduces anxiety and stabilizes mood through GABAergic and enkephalin modulation. Together, they support both the "accelerator" and "stabilizer" of cognitive performance.

• Are these approved medications anywhere?

  Both Semax and Selank are approved prescription medications in Russia with extensive clinical use histories. They are available for research purposes in the United States.

• Why intranasal administration?

  Intranasal delivery provides direct access to the CNS via the olfactory and trigeminal nerve pathways, bypassing the blood-brain barrier. This is the primary route used in published clinical research for both peptides.

• What purity standard is used?

  ≥99% purity by HPLC and mass spectrometry. Certificate of Analysis provided.